je.st
news
Tag: phase
Mercks ZEPATIER (Elbasvir and Grazoprevir) Showed Superiority on Efficacy and Safety Endpoints Compared to Sofosbuvir Plus Peginterferon and Ribavirin Treatment Regimen in Phase 3 Trial
2016-04-14 07:00:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. Results From C-EDGE Head-to-Head Study in Patients with Chronic Hepatitis C Genotypes 1 or 4 Infection Presented at The International Liver Congress 2016 KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the presentation of results from C-EDGE Head-to-Head, the companys comparative, Phase 3, open-label clinical trial evaluating the efficacy and safety of ZEPATIER (elbasvir and grazoprevir) 50mg/100mg tablets versus a regimen of sofosbuvir 400mg tablets plus peginterferon and ribavirin (pegIFN/RBV) in treatment-nave and pegIFN/RBV treatment-experienced patients with chronic hepatitis C (HCV) genotype (GT) 1 or GT4 infect Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558Sarra Herzog, 201-669-6570orInvestors:Teri Loxam, 908-740-1986Amy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: in
safety
treatment
trial
Phase Identification and Conductor Cleaning
2016-04-10 22:42:00| Transmission & Distribution World
EDM International Inc.s PhaseTrakker AP30 Atomic provides phase Identification for any environment - indoor or outdoor. read more
Tags: phase
identification
cleaning
conductor
Cree's Growth Phase Appears Dead, A Fair Value For The Stock Is $20
2016-04-07 19:40:03| Electronics - Topix.net
All three of the company's segments have negative revenue growth for Q3. Nine month year-over-year revenue for fiscal 2016 also has turned downward.
Cree's Growth Phase Appears Dead, A Fair Value For The Stock Is $20
2016-04-07 19:38:33| Semiconductors - Topix.net
All three of the company's segments have negative revenue growth for Q3. Nine month year-over-year revenue for fiscal 2016 also has turned downward.
SENER Signs Contracts to Develop New Mechanism for Phase C and Phase D of Sentinel-1, Sentinel-2 and Sentinel-3
2016-04-04 01:00:00| Naval Technology
The SENER engineering and technology group has signed new contracts for the Phase C and Phase D of the Sentinel-1, Sentinel-2 and Sentinel-3 satellites.
Sites : [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] next »